JKHY Form 4: Director equity award of 1,220 restricted stock units
Rhea-AI Filing Summary
Jack Henry & Associates (JKHY) disclosed an equity compensation grant to one of its directors on a Form 4. On November 17, 2025, the reporting person received 1,220 restricted stock units (RSUs), each representing the economic equivalent of one share of JKHY common stock. The RSUs were reported as derivative securities with a price of $0, reflecting that they are an award rather than a market purchase.
The RSUs will vest in full on the earlier of the day before Jack Henry & Associates' 2026 annual meeting of stockholders or the first anniversary of the grant date. Once vested, each unit entitles the holder to receive either one share of common stock or, at the company’s option, the cash value of that share. This filing records a routine director compensation grant and confirms the director’s updated beneficial holdings.
Positive
- None.
Negative
- None.
FAQ
What insider transaction did Jack Henry & Associates (JKHY) report on this Form 4?
The company reported that a director received 1,220 restricted stock units (RSUs) on November 17, 2025, as an equity-based compensation award.
Who is the reporting person in the JKHY Form 4 filing?
The reporting person is Curtis A. Campbell, identified in the filing as a director of Jack Henry & Associates. The Form 4 is signed by Andrew Potter acting under power of attorney for Campbell.
How many Jack Henry & Associates RSUs were granted and at what price?
The director was granted 1,220 restricted stock units. The RSUs are shown with a price of $0, indicating they are an award rather than shares purchased in the market.
When do the 1,220 JKHY restricted stock units vest?
The RSUs vest in full on the earlier of (1) the day before Jack Henry & Associates' 2026 annual meeting of stockholders or (2) the first anniversary of the November 17, 2025 grant date.
What does each JKHY restricted stock unit represent for the director?
Each RSU is the economic equivalent of one share of Jack Henry & Associates common stock and gives a contingent right to receive either one share of common stock or, at the company’s option, the cash value of that share upon vesting.
Is this JKHY Form 4 related to derivative or non-derivative securities?
The reported transaction involves derivative securities, specifically restricted stock units listed in Table II of the Form 4. Table I for non-derivative securities does not show a specific transaction in this excerpt.